 |
 |
SHANGHAI, May 7, 2018 /PRNewswire/ -- Fullerton Healthcare Corporation Limited ("Fullerton Health" or the "Group"), a leading managed care provider in Asia Pacific, announced today that Fullerton Health China Limited ("Fullerton China") has completed the acquisition of a majority stake of Jiangsu Kangruijia Medical Investment Management Co., Ltd and its subsidiaries ("Global Doctor").
Global Doctor, founded in 1999, is one of the largest primary care clinic groups in China with 18 clinics in Nanjing, Chongqing, Chengdu, Dongguan, Guangzhou, Nanchang and Suzhou. The company has a strong reputation for providing quality healthcare services and is supported by experienced multi-lingual medical staff and a broad range of diagnostic and treatment modalities.
Following the RMB 800 million investment into Fullerton Health by Ping An Capital Co., Ltd announced in November last year, Global Doctor is the first investment of Fullerton Health in China. The acquisition is aligned with Fullerton Health's strategy of developing a strong presence in China, and allows it to extend its reach to corporate clients beyond the core target markets of Shanghai and Beijing.
Dr. Daniel Chan, President, Fullerton China commented: "I am thrilled to welcome the Global Doctor team to join Fullerton Health today. With the deepening of China's healthcare reform, there is no better time for Fullerton Health to expand into the Chinese market. As a leading provider of corporate healthcare solutions in the Asia Pacific region with a proven track record, Fullerton Health is uniquely positioned to offer quality healthcare that is affordable and accessible in China. This is an important acquisition for us and is strategically aligned with Fullerton Health's expansion plan in China. We look forward to working closely together with Global Doctor to other cities, including Wuhan and Xi'an."
Gao Yunhu, Managing Director, Global Doctor said, "The investment by Fullerton Health, establishing themselves as our majority shareholder, is an exciting development for Global Doctor. The acquisition enables Global Doctor to tap into Fullerton Health's expansive network and wealth of experience across 8 geographies in Asia Pacific, further enhancing our operations and ability to provide quality clinical care in China. With strong track record and its position as the pre-eminent corporate healthcare services provider across Asia Pacific, Fullerton Health is the ideal partner for Global Doctor as we embark on the next stage of our development."
- ENDS -
About Fullerton Health
Fullerton Health is a leading managed care provider in Asia Pacific. Founded in Singapore in 2011, today they own over 500 medical centres and have a large global network of medical providers across 8 countries in Asia. As a vertically integrated medical provider, Fullerton Health's value proposition entails the integration of healthcare service offerings with customized management and advisory capabilities, in line with its mission to transform Asian healthcare and make it affordable and accessible for enterprise clients.
For more information on Fullerton Health, please visit http://www.fullertonhealth.com/.
About Global Doctor
Founded in 1999, Global Doctor currently operates 18 clinics in Nanjing, Chongqing, Chengdu, Dongguan, Guangzhou, Nanchang and Suzhou. It provides clinical care across a broad range of medical disciplines, including family medicine, gynecology, pediatrics, traditional Chinese medicine, dentistry, counselling, physiotherapy and rehabilitation, health screening and health management, where 24-hour medical consultation hotline and multi-language medical support are available.
Global Doctor, certified by the European Diplomatic Association, is the first medical institution in the PRC that passed the EU TEMOS quality certification in 2016.
Media Contact:
Brunswick Group
Ziya Yang
FHCN@brunswickgroup.com
+86 (10) 59608600
Logo - https://photos.prnasia.com/prnh/20180504/2124502-1-a
Logo - https://photos.prnasia.com/prnh/20180504/2124502-1-b
